StockData
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Cresco Labs Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 6, 2026
$0.58−0.02 (-3.13%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

About Cresco Labs

Medicinal Chemicals & Botanical Products, SIC 2833

Cresco Labs Inc. is a cannabis company that cultivates, produces, and sells cannabis and non-cannabis products. The company operates through two primary segments, wholesale and dispensary, supplying its own brand portfolio alongside partner products to consumers and commercial clients. Its retail footprint serves adult-use customers as well as registered patients seeking medical cannabis products.

The business conducts its operations within the United States, managing wholesale distribution networks, specialized cultivation and production facilities, and retail dispensaries across multiple states, including Illinois, Pennsylvania, New York, Ohio, and California. Incorporated in British Columbia, Canada, Cresco Labs maintains its principal executive offices and headquarters in Chicago, Illinois.

Summary of the business section of Cresco Labs's latest annual report, written by StockData.

Company profile

Company

Legal name
Cresco Labs Inc.
Headquarters
Chicago, IL
Address
600 W. Fulton Street, Suite 800 60661
Phone
(312) 929-0993
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
A1
Fiscal year ends
December 31
Auditor
Marcum LLP, New York, NY

Stock & identifiers

Ticker
CRLBF
Exchange
OTC
Shares outstanding
503M, Dec 31, 2025
Filer category
<br>Emerging growth company
SEC CIK
1832928
CUSIP
22587M106
ISIN
US22587M1062
EIN
98-1505364

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Cresco Labs's leadership is listed in its proxy statement (Form DEF 14A).